Completed NA INTERVENTIONAL 3-arm NCT01192477

Ozone Cardiovascular Effects in Genetically Susceptible People (OZCARD)

Sponsor: Conservation of Clean Air and Water in Europe (CONCAWE)

Conditions Healthy

Interventions Ozone

Updated 5 times since 2017 Last updated: Dec 2, 2013 Started: May 31, 2011 Primary completion: Aug 31, 2012 Completion: Aug 31, 2012

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A NA clinical study on Healthy, this trial is completed. The trial is conducted by Conservation of Clean Air and Water in Europe (CONCAWE) and has accumulated 5 data snapshots since 2011. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Jan 2021 — Jul 2024 [monthly]

Completed NA
Jun 2018 — Jan 2021 [monthly]

Completed NA
Jan 2017 — Jun 2018 [monthly]

Completed NA

First recorded

May 2011

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Conservation of Clean Air and Water in Europe (CONCAWE)
Exxon Mobil
National Institute of Environmental Health Sciences (NIEHS)
University of Rochester

Data source: University of Rochester

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Rochester, United States